...
首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >DRUG UTILIZATION STUDY OF ANTIHYPERTENSIVE TREATMENT BEING PRESCRIBED IN PATIENTS COMING TO MEDICINE OPD OF A TERTIARY CARE HOSPITAL IN NORTHERN INDIA
【24h】

DRUG UTILIZATION STUDY OF ANTIHYPERTENSIVE TREATMENT BEING PRESCRIBED IN PATIENTS COMING TO MEDICINE OPD OF A TERTIARY CARE HOSPITAL IN NORTHERN INDIA

机译:印度北部医学院医学opmopment的患者抗高血压治疗药物利用研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction: Hypertension, is a global public health issue. It is a significant contributor to rising morbidity and mortality because of its associations with cardiovascular, renal and cerebrovascular complications. Given the prevalence and impact of the disease on health care a drug utilization study becomes essential to determine the current drug utilization pattern. Materials and Methods: 127 patients of hypertension coming to the OPD of medicine of King George’s Medical University were enrolled in the study after screening and giving consent. The data from the prescription of the drugs were recorded in pre-specified case record forms and analyzed for drug utilization parameters. Results: The average number of drugs encountered per prescription was 4. Whereas prescriptions with the generic name were 38% and drugs from an essential drug list were found to be 74%. The most commonly prescribed antihypertensive group was calcium channel blocker (25.1%) in monotherapy followed by angiotensin receptor blocker (21.2%). In combination therapy, the most commonly prescribed combination was found to be calcium channel blocker + angiotensin receptor blocker (17.3%). The drugs were prescribed in doses either equal to or less than the WHO DDD prescribed except telmisartan which was prescribed in a higher dose. A major finding was decreased in the angiotensin-converting enzyme inhibitor prescription and rise in angiotensin receptor blocker. Conclusion: Results of our study showed a lower rate of polypharmacy reporting and adherence to a national essential list of medications. The drugs being prescribed also fell well within the WHO recommended Daily Defined Dose (DDD).
机译:引言:高血压,是全球公共卫生问题。由于其与心血管,肾和脑血管并发症的关联,它是发病率和死亡率上升和死亡率的重要贡献者。鉴于疾病对医疗保健的患病率和影响,药物利用研究对于确定目前的药物利用模式至关重要。材料和方法:127例高血压患者展示了乔治医科大学医学院的药物的OPD,在筛选和同意后注册了该研究。来自药物处方的数据以预先规定的病例记录表格记录并分析了药物利用参数。结果:每处方药的平均药物数量为4.而通用名称的处方均为38%,发现来自必要药物清单的药物为74%。最常见的抗高血压群是单疗法中的钙通道阻滞剂(25.1%),然后是血管紧张素受体阻滞剂(21.2%)。在联合治疗中,发现最常见的组合是钙通道阻滞剂+血管紧张素受体阻滞剂(17.3%)。药物以等于或小于除了在更高剂量的替代品规定的替代品之前规定的DDD规定的药物。血管紧张素转化酶抑制剂处方和血管紧张素受体阻滞剂上升的重大发现减少。结论:我们的研究结果表明,复数报告率较低,并遵守国家基本药物的药物。在谁建议日常定义的剂量(DDD)中,处方的药物也在下降。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号